Hepatitis Patients Face High Risk of Fatty Liver Disease
Nearly half of adults with chronic viral hepatitis also have metabolic liver disease, which may worsen fatigue.
Updated on Oct. 29, 2026 in Diseases — General
Live Poll
Should patients with chronic liver issues prioritize managing weight and diabetes to improve daily well-being?
Nearly half of individuals living with chronic hepatitis B or C also suffer from metabolic dysfunction-associated steatotic liver disease, according to a 2026 registry analysis. This dual diagnosis is linked to increased fatigue and a reduced quality of life for millions of affected patients.
Why it matters
Identifying these overlapping conditions is vital, as the presence of fatty liver disease in patients with viral hepatitis can exacerbate health complications and significantly impact day-to-day well-being.
A 2026 analysis of 4,649 patients from the Global Liver Registry found that metabolic dysfunction-associated steatotic liver disease was present in 49% of the HBV group and 47% of the HCV group. The researchers used a Hepatic Steatosis Index of 36 or higher paired with at least one cardiometabolic risk factor to define the condition.
The players
Global Liver Registry
An international database that compiles clinical data to track liver disease trends and treatment outcomes.
World Health Organization
The United Nations agency responsible for international public health, which monitors global hepatitis infection and mortality rates.
The details
The condition was identified by analyzing clinical data and patient-reported outcomes to assess the prevalence of metabolic dysfunction alongside chronic viral infections. When metabolic dysfunction-associated steatotic liver disease co-occurs with hepatitis, it adds a layer of systemic stress to the liver that may explain why patients report more pronounced physical fatigue. This analysis serves as a marker for clinicians to evaluate metabolic health in patients already managed for viral hepatitis.
Timeline
In 2024, approximately 287 million people were living with chronic hepatitis B or C infections.
The World Health Organization published its global hepatitis report on April 28, 2026.
This study analyzing viral hepatitis and liver disease associations was published in 2026.
Health Landscape
This research highlights a significant clinical intersection that often complicates the management of chronic viral infections. It expands on the burden of disease estimates established by the World Health Organization's Global Hepatitis Report by detailing the prevalence of common metabolic comorbidities.
If you are living with chronic hepatitis B or C, it is worth discussing your metabolic health and liver screening results with your doctor. Paying attention to unexplained fatigue or quality-of-life changes can help you and your care team address potential underlying metabolic issues early.
The takeaway
Patients with chronic viral hepatitis should be aware that metabolic health significantly influences overall physical well-being. Consider asking your physician about screening for metabolic dysfunction-associated steatotic liver disease during your next routine checkup.
Further reading
Learn more about managing chronic conditions in our Diseases — General section.
Source note: This article includes information reported by Ajmc.
Live Poll
Should patients with chronic liver issues prioritize managing weight and diabetes to improve daily well-being?
